ArticleBMC cancer2022

Mainstream germline genetic testing in men with metastatic prostate cancer: design and protocol for a multicenter observational study.

Michiel Vlaming et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.